| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ARD.2008.094813 |
| P698 | PubMed publication ID | 18930995 |
| P50 | author | David A. Isenberg | Q42326409 |
| P2093 | author name string | G Hendrickx | |
| T W J Huizinga | |||
| F De Keyser | |||
| B R Lauwerys | |||
| D Elewaut | |||
| J Dehoorne | |||
| R Joos | |||
| F Houssiau | |||
| L Cebecauer | |||
| I E A Hoffman | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 412-415 | |
| P577 | publication date | 2008-10-17 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus | |
| P478 | volume | 68 |
| Q44003262 | Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus |
| Q48361761 | Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus. |
| Q40250594 | Anti-ribosomal P antibody: a multicenter study in childhood-onset systemic lupus erythematosus patients |
| Q22299246 | Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus |
| Q33775707 | Autoantibodies against C1q as a Diagnostic Measure of Lupus Nephritis: Systematic Review and Meta-analysis |
| Q38223293 | Childhood onset systemic lupus erythematosus: how is it different from adult SLE? |
| Q40995930 | Childhood-onset systemic lupus erythematosus in Singapore: clinical phenotypes, disease activity, damage, and autoantibody profiles |
| Q51196776 | Children and adolescents with SLE: not just little adults. |
| Q33755568 | Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry IX: Clinical Features and Survival of Childhood-Onset Systemic Lupus Erythematosus in China |
| Q41317956 | Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE. |
| Q35743904 | Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus |
| Q86015625 | Clinical applications of the indirect immunofluorescence assay for detection of anticell membrane-associated DNA antibodies in juvenile systemic lupus erythematosus |
| Q50285114 | Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study |
| Q34610794 | Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus |
| Q33423725 | Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients. |
| Q35620320 | Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus |
| Q40038921 | Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis |
| Q33397369 | Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis |
| Q33431990 | Differences in disease phenotype and severity in SLE across age groups |
| Q47234564 | Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE. |
| Q34554770 | Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients |
| Q36903145 | Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial. |
| Q83774254 | Familial juvenile systemic lupus erythematosus in Arab children |
| Q47939662 | Flares in Chinese systemic lupus erythematosus patients: a 6-year follow-up study |
| Q48695732 | Gastrointestinal system manifestations in juvenile systemic lupus erythematosus. |
| Q36501033 | IFNα enhances the production of IL-6 by human neutrophils activated via TLR8. |
| Q35426946 | Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus |
| Q42220143 | Infections and systemic lupus erythematosus |
| Q47604517 | Initial digital vasculitis in a large multicenter cohort of childhood-onset systemic lupus erythematosus. |
| Q51021785 | Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus. |
| Q44593708 | Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison. |
| Q46867176 | Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome. |
| Q26849746 | Juvenile systemic lupus erythematosus: review of clinical features and management |
| Q95592748 | Lupus nephritis |
| Q91738696 | Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus |
| Q27006752 | Nailfold capillaroscopy in pediatrics |
| Q34310715 | Neurologic manifestations of systemic lupus erythematosus in children and adults |
| Q34720014 | Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity |
| Q33723511 | Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? |
| Q38771936 | Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus |
| Q37777642 | Prevalence and burden of pediatric-onset systemic lupus erythematosus |
| Q38374309 | Reviewing the recommendations for lupus in children |
| Q40250609 | Ribosomal P antibody: 30 years on the road |
| Q33882185 | Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides |
| Q26773130 | SLE: Another Autoimmune Disorder Influenced by Microbes and Diet? |
| Q35748778 | Scaly ear rash as the herald of a young girl with juvenile systemic lupus erythematosus |
| Q47267579 | Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus |
| Q39043261 | Serum interleukin-17 in Egyptian children with systemic lupus erythematosus: is it related to pulmonary affection? |
| Q86096678 | Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus |
| Q41680587 | Similarities and differences between pediatric and adult patients with systemic lupus erythematosus |
| Q55282858 | Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. |
| Q36295937 | Taxonomy for systemic lupus erythematosus with onset before adulthood |
| Q38134058 | The incidence, diagnostic clinical manifestations and severity of juvenile systemic lupus erythematosus in New Zealand Maori and Pacific Island children: the Starship experience (2000-2010). |
| Q37504701 | The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus |
| Q26865441 | Type I interferon blockade in systemic lupus erythematosus: where do we stand? |
| Q37690103 | Update on differences between childhood-onset and adult-onset systemic lupus erythematosus |
| Q89030349 | [Connective tissue diseases in adolescents] |
Search more.